Sandugash Sadikaliyeva

Sandugash Sadikaliyeva

Auto-generated profile, based on publicly available information

Sandugash Sadikaliyeva

Laboratory for Control of Technologies and Biopreparations, Research Institute for Biological Safety Problems LLP, Guardeyskiy uts 080409, Kazakhstan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2024 in Eurasian Journal of Applied Biotechnology
Verified
Journal Article
Open access
PDF file
SSS.O. Sadikaliyeva
S.O. Sadikaliyeva
EKE.Zh. Kalimolda
E.Zh. Kalimolda
ZAZh.S. Abay
Zh.S. Abay
YSYe.A. Shayakhmetov
Ye.A. Shayakhmetov
SMSabina Ulanovna Moldagulova
Sabina Ulanovna Moldagulova
ANAinur Nurpeisova
Ainur Nurpeisova
This article presented the results of a study on the impact of physicochemical factors on the biological activity of the SARS-CoV-2 coronavirus isolated from a dog in the Republic of Kazakhstan. The results indicated that storing the virus at a temperature of -70°C led to a decrease in viral activity, similar to the effect observed when stored at room temperature. Storage at +40°C resulted in complete inactivation of the virus. The study on the effect of various concentrations of ionic and non-ionic detergents revealed that exposure to the ionic detergent DOC at concentrations of 0.1% and 0.5% caused a decrease in viral activity, while no change was observed at a concentration of 0.01%. The detergent SDS, at concentrations of 0.01%, 0.1%, and 0.5%, reduced the biological activity of the virus from the initial titer (5.25 lg TCID50/cm³) to 4.00 lg TCID50/cm³. Similarly, the use of non-ionic detergents, Triton X-100 and Tween-20, led to a reduction in viral activity from the initial titer to 4.50 lg TCID50/cm³. The effect of pH in acidic, neutral, and alkaline environments on the biological activity of the virus was also studied. A decrease in viral activity was observed at acidic and alkaline pH levels, whereas a neutral pH environment had no impact on viral activity.

27 November 2024
Verified
Conference Paper
Closed access
SSSandugash Sadikaliyeva
Sandugash Sadikaliyeva
KSKamshat Shorayeva
Kamshat Shorayeva
ZAZhandos Abay
Zhandos Abay
KJKuanysh Jekebekov
Kuanysh Jekebekov
YSYeraly Shayakhmetov
Yeraly Shayakhmetov
ANAinur Nurpeisova
Ainur Nurpeisova
This article presents the results of studies on biological samples collected from 640 swabs taken from dogs and cats across various regions of the Republic of Kazakhstan. These samples were part of a monitoring study on the spread of coronavirus among domestic animals. Total RNAs were isolated using the magnetic sorption method with the ALPREP kit and subsequently analyzed with the ALSENSE-SARS-CoV-2 RT-qPCR kit. Real-time RT-PCR analysis revealed that 104 samples tested positive within 22–37 amplification cycles. These positive samples were then cultured in Vero cell lines to confirm the presence of the virus. The biological activity of the resulting virus-containing suspension was determined using the Reed-Muench method. During cultivation, one viral isolate with a biological activity of 5.83±0.08 lg TCID50/ml was obtained. A microphotograph of the virus was taken using an electron microscope to determine its size, shape, and structure, which confirmed its morphology corresponding to the Coronaviridae family. The data obtained further indicate that domestic animals can suffer from and carry coronavirus. It is becoming increasingly evident that the virus can infect and replicate in the organs of various farm and domestic animals.

15 April 2020 in SERIES OF BIOLOGICAL AND MEDICAL
Verified
Journal Article
Closed access
ETE. T. Tailakova
E. T. Tailakova
SSS. О. Sadikaliyeva
S. О. Sadikaliyeva
GSGaukhar Shynybekova
Gaukhar Shynybekova
AAA. K. Abubakirova
A. K. Abubakirova
KSK. T. Sultankulova
K. T. Sultankulova
OCOlga Chervyakova
Olga Chervyakova
Brucellosis is still an important public health problem as long as natural reservoirs of infection exist. Currently, live attenuated vaccines based on strains S19, RB51 and Rev1 are used for the prevention of brucellosis in animals, the main disadvantage of which is virulence for humans. However, animal immunization programs should be implemented to reduce the incidence of humans. The development of safe and effective new generation vaccines using “omix” technology is a promising direction of vaccinology. A number of immunogenic Brucella proteins that elicit both a humoral and cellular immune response has been identified. The aim of these research was to optimize the expression and purification conditions of the Brucella spp. recombinant proteins L7/L12 and SodC. As a result, expressing plasmids pET/Br-L7/L12 and pET/Br-SodC were obtained. The parameters of target genes expression in E. coli were established and the method for purification of recombinant proteins was optimized. Purification of the L7/L12 protein was performed under hybrid conditions on HisPur agarose using a binding buffer containing 6 M guanidine hydrochloride, a wash buffer with 20 mM imidazole and an elution buffer with 300 mM imidazole. Protein SodC was purified under denaturing conditions with the addition of 1 % Triton X-100 and 1 % sodium deoxycholate to the lysis buffer. Inclusions were solubilized with a buffer containing 8 M urea and 5 mM imidazole. The target protein was eluted from HisPur agarose with buffer containing 8 M urea and 100 mM imidazole. The use of modified purification protocols made it possible to obtain purified recombinant proteins with a yield of 13 mg/L for the L7/L12 protein and 10 mg/L for the protein SodC, respectively. The specificity of the proteins was confirmed by a Western blot. Immunization of mice with recombinant proteins led to the production of specific antibodies, the titer of which in ELISA was 1:20480 and 1:20480, respectively.

6 September 2025 in Veterinary World
Verified
Journal Article
Open access
ANAinur Nurpeisova
Ainur Nurpeisova
ZAZhandos Abay
Zhandos Abay
MKMarkhabat Kassenov
Markhabat Kassenov
NSNazym Syrym
Nazym Syrym
SSSandugash Sadikaliyeva
Sandugash Sadikaliyeva
KSKamshat Shorayeva
Kamshat Shorayeva
Background and Aim: Bovine tuberculosis (bTB), caused by Mycobacterium bovis, remains a significant zoonotic and eco­nomic threat globally. Despite the long-standing use of the Bacillus Calmette-Guérin (BCG) vaccine, its inconsistent efficacy and interference with surveillance tests underscore the need for alternative approaches. This study evaluated the safety, immunogenicity, and protective efficacy of a novel influenza vector-based vaccine expressing M. bovis antigens ESAT-6 and TB10.4, formulated with or without an adjuvant. Materials and Methods: Recombinant influenza A viruses expressing ESAT-6 and TB10.4 were constructed using reverse genetics and incorporated into vaccine formulations. Guinea pigs and calves were immunized with adjuvanted and non-adjuvanted formulations, followed by challenge with a virulent M. bovis strain. Safety was assessed through clinical observation and histopathology. Immune responses were monitored using interferon-gamma (IFNγ) enzyme-linked immu­nosorbent assay, and protection was evaluated through organ damage indices, bacterial load, and survival rates over a 12-month period. Results: Both formulations were safe and well-tolerated in guinea pigs and calves, with no adverse clinical signs. The non-adjuvanted vaccine induced the highest and most sustained IFNγ response, peaking between 2 and 5 months post-vac­cination. In guinea pigs, the protection index reached +0.60 lg in the non-adjuvanted group versus +0.2 lg in the adjuvanted group. In calves, lung bacterial load was reduced to 1.83–1.93 lg colony-forming unit (CFU) in vaccinated animals compared with 5.8 lg CFU in unvaccinated controls. Histopathological examination confirmed minimal tissue damage in the vaccinated groups. Both vaccine formulations demonstrated protective efficacy equivalent to or better than BCG, with the non-adju­vanted version showing superior performance. Conclusion: This novel influenza vector-based vaccine expressing ESAT-6 and TB10.4 antigens elicits strong, long-lasting cellular immunity and provides significant protection against M. bovis infection in guinea pigs and calves. The adjuvant-free formulation demonstrated higher immunogenicity, simplified production, and minimal adverse reactions, positioning it as a promising alternative to BCG for bTB control in livestock. Keywords: Bovine tuberculosis, calves, ESAT-6, guinea pigs, interferon-gamma, influenza vector, Mycobacterium bovis, protective efficacy, TB10.4, vaccine.

6 October 2026 in Eurasian Journal of Applied Biotechnology
Verified
Journal Article
Open access
PDF file
YBYe.B. Burashev
Ye.B. Burashev
RRR.A. Rystaeva
R.A. Rystaeva
ZOZ.D. Omarova
Z.D. Omarova
TATakhmina Argimbayeva
Takhmina Argimbayeva
НАНурдос Аубакир
Нурдос Аубакир
OCOlga Chervyakova
Olga Chervyakova
Brucellosis remains a major zoonotic disease of global public health and veterinary importance. Recombinant capripoxvirus vectors have emerged as promising platforms for the development of next-generation vaccines owing to their favorable safety profile, genomic stability, and ability to induce robust immune responses. The aim of this study was to optimize serum-free cultivation conditions for the recombinant sheeppox virus strain SSPV (TK) OMP16 expressing the Brucella outer membrane protein OMP16 in Vero cell culture. The recombinant virus was propagated on Vero cell monolayers using Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 2% fetal bovine serum or serum-free OptiPro™ medium containing 1% L-glutamine. Adaptation to serum-free conditions was achieved by five sequential blind passages in Vero cells. Viral biomass accumulation was evaluated at multiplicities of infection (MOI) of 0.01, 0.05, 0.1, and 0.5 TCID50/cell during cultivation periods ranging from 12 to 120 h. Infectious activity was determined by TCID50 assay in Vero cell culture. Serum-free OptiPro medium supported efficient replication of the recombinant virus and produced infectious titers comparable to those obtained in conventional serum-containing DMEM. The highest infectious activity of recombinant strain SSPV (TK) OMP16 was 6.25 log TCID₅₀/cm³ at an MOI of 0.1 TCID₅₀/cell at 96 h post-infection. Sterility testing confirmed the absence of bacterial and fungal contamination in all virus suspensions. The optimized serum-free cultivation protocol provides a standardized approach for propagation of recombinant capripoxvirus vectors and represents a practical basis for further development and scale-up of recombinant vaccine production against brucellosis.

17 December 2023
Verified
Conference Paper
Closed access
ANAinur Nurpeisova
Ainur Nurpeisova
ZAZhandos Abay
Zhandos Abay
KSKamshat Shorayeva
Kamshat Shorayeva
SSSandugash Sadikaliyeva
Sandugash Sadikaliyeva
BYBolat Yespembetov
Bolat Yespembetov
YAYergali Abduraimov
Yergali Abduraimov
Two recombinant influenza A virus vectors expressing the ESAT 6 and TB10.4 mycobacterial proteins from the nonstructural (NS) gene were constructed via reverse genetics technique to develop a specific means of prophylaxis for bovine tuberculosis. We experimented to determine optimal conditions for growing recombinant vectors in Vero cell culture and chick embryos. This study established that the maximum amount of virus builds up in a Vero cell culture with the Dulbecco′s Modified Eagle′s Medium (DMEM) serum-free medium. However, using cell culture to produce vector vaccines is labourintensive and inefficient. An alternative way, a traditional, time-tested technique, is provided by growing samples in chick embryos. One of the advantages of this technique is its affordability and availability, enabling easy scale-up of vaccine production. In the optimization experiments, the FLU-ΔNS_ESAT 6 and FLU-ΔNS_ТВ10.4 viruses constructed were inoculated into 10-day-old chick embryos. It was determined that the optimal incubation temperature that led to the highest virus build-up was 37 ± 0.5 °С. And the infectious activity level of the FLU-ΔNS_ESAT 6 recombinant vector was at 8.95 ± 0.07 log10EID50 0.2 cm-3, while that of the FLU-ΔNS_ТВ10.4 was at 9.20 ± 0.07 log10EID50 0.2 cm-3, what was provided by infectious doses of 1000–10000 EID50, which makes it possible to create a virus-containing material with a hemagglutination activity level of 1:64. The size of recombinant vector amplicons expressing proteins ТВ10.4 and ESAT 6 was 1170 bp and 1175 bp, respectively. Electron microscopy images confirm that the developed virions are morphologically similar to the avian influenza virus.